Molecular Diagnostics and Biological Safety — 2021

28-29 april 2021 г.
COVID-19: epidemiology, diagnosis and prophylaxis
Online congress with international participation Molecular Diagnostics and Biological Safety 2021. COVID-19: Epidemiology, Diagnosis and Prophylaxis is held from 28 to 29 April 2021. The Congress was first launched in 2003.

The issue of coronavirus infection remains high on the international agenda. The pandemic has currently affected over 200 countries globally, with more than 100 million cases and 2 million deaths*.

What do we know about the infection today? What is the perception of COVID-19 a year after the pandemic onset? What are the challenges that the healthcare system, the society and the state face today? The upcoming Congress will mainly focus on COVID-19 research, new diagnostic methods, specific and non-specific preventive care, hygiene and infection control in hospitals and other relevant issues related to the new coronavirus infection.
Leading national and foreign experts in epidemiology and molecular diagnostics of infectious diseases, representatives of scientific institutions and R&D establishments, heads and staff of laboratory diagnostics departments of large clinics and other healthcare institutions of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, the Russian Academy of Sciences, the Ministry of Health of the Russian Federation and other departments will participate in the Online Congress.
*Source: JHU CSSE COVID-19 Data, as of 11 February 2021.
Acceptance of applications for the publication of reports and abstracts is closed

Scientific Agenda of the Congress

Challenges of Modern Times and the Role of Molecular Diagnostics in Ensuring Biological Safety.
Current Issues of the Epidemiology of the New Coronavirus Infection COVID-19.
The Role of Molecular Diagnostics in the Epidemiology of COVID-19.
Creation and Large-Scale Production of Reagent Kits (Test Systems) for the COVID-19 Diagnosis.
Modern Sequencing Technologies and Bioinformatics in the COVID-19 Clinic and Epidemiology.
Monitoring of the New Coronavirus Infection SARS-Cov-2 Pathogen and the State of Population Immunity in COVID-19.
Specificity of the Clinical Progression and Areas of Pathogenetic Therapy of COVID-19.
First Results of COVID-19 Immunoprophylaxis. Scientific and Practical Issues of Mass Vaccination of the Population.
Epidemiological Surveillance of COVID-19.
COVID-19 and Antibiotic Resistance.
Non-Specific Prophylaxis of the New Coronavirus Infection COVID-19. Methods for Indoor Air Cleaning and Disinfection.

Target audience

Healthcare professionals and researchers
Highly topical scientific agenda and CME points.
Students and postgraduate students
Prominent speakers, interesting presentations, new knowledge and contacts.
Heads of research institutions
Joint strategies, heated debates and topical issues.
Business leaders
New contacts, ideas and partnership.
The 2020 Congress in figures
countries of registration
countries of viewing
Russian regions
3 596
attendees for 3 days


Стать участником

Do you want to take part in the Congress?

Please fill in the registration form.
This will only take 1–2 minutes.
After filling in and sending the form you can also register your colleague.
Participation is free!

Media relations

Perekatova Tatyana Valeryevna
Head of Press Centre of FBIS Central Research Institute of Epidemiology of Rospotrebnadzor

Technical organization and sponsorship

Lvov Mikhail Gennadyevich
Project Manager
Phone: +7 (495) 617-36-79
Babicheva Elena Vladimirovna
Public Relations Manager
Phone: +7 (926) 917-44-96
Office phone: + 7 (495) 974-96-46, доб. 1308
Mobile phone: +7 (926) 295-59-72
Leading Researcher of the Department of Molecular Diagnostics and Epidemiology of FBIS Central Research Institute of Epidemiology of Rospotrebnadzor, Doctor of Medical Sciences, Professor
Tvorogova Mariya Glebovna
Office phone: +7 (495) 974-96-46, доб. 1122
Mobile phone: +7 (905) 360-87-77
Advisor of the Organisational and Methodological Department of the Administrative and Management Division of FBIS Central Research Institute of Epidemiology of Rospotrebnadzor, Doctor of Medical Sciences, Associate Professor
Ugleva Svetlana Viktorovna

Scientific agenda development